UC-San Francisco: Could This Molecule Be 'Checkmate' for Coronaviruses Like SARS-CoV-2?
April 24, 2025
April 24, 2025
SAN FRANCISCO, California, April 24 -- The University of California San Francisco campus issued the following news release:
* * *
Could this Molecule be 'Checkmate' for Coronaviruses like SARS-CoV-2?
Powerful drug candidates perform better than Paxlovid against SARS-CoV-2 and could head off future coronavirus pandemics. The research has stalled since the grant was cut.
By Levi Gadye
Ateam at UC San Francisco and Gladstone . . .
* * *
Could this Molecule be 'Checkmate' for Coronaviruses like SARS-CoV-2?
Powerful drug candidates perform better than Paxlovid against SARS-CoV-2 and could head off future coronavirus pandemics. The research has stalled since the grant was cut.
By Levi Gadye
Ateam at UC San Francisco and Gladstone . . .